Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06007170` - Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients Without Glottal Enlargement	N/A
Completed	`NCT05285423` - A Novel Approach for VC Lateralization, With Prolene Suture Stabilized Over Prolene Mesh	N/A
Recruiting	`NCT06007144` - Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients With Single-sided Glottal Enlargement	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT06007170 - Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients Without Glottal Enlargement

N/A

Completed

NCT05285423 - A Novel Approach for VC Lateralization, With Prolene Suture Stabilized Over Prolene Mesh

N/A

Recruiting

NCT06007144 - Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients With Single-sided Glottal Enlargement

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03980275
Study type	Observational
Source	Weill Medical College of Cornell University
Contact	Babak Sadoughi, MD
Phone	646-962-4712
Email	bas9049@med.cornell.edu
Status	Recruiting
Phase
Start date	December 10, 2019
Completion date	June 30, 2025

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms